Register for our free email digests:
Eli Lilly & Co.
www.lilly.com
Latest From Eli Lilly & Co.
J&J Targets Tremfya Growth In PsA
Teriparatide Trickles In For Richter
Richter’s Terrosa biosimilar to Lilly’s Forsteo teriparatide brand made a modest start in Europe. But the Hungarian group still posted nine-month Pharmaceutical sales growth of 8.1%.
US FDA Revokes Orphan Drug Designation For Indivior’s Sublocade
In first-of-its-kind decision, agency concludes it relied on unreasonable assumptions regarding total market size, and failed to consider information about other dosage formulations, in granting designation for buprenorphine under the cost recovery provision; however, the FDA reaffirms that scope of Sublocade’s three-year exclusivity will keep Braeburn’s Brixadi off the market for another year.
Sun's China, Japan Plans Gather Pace
Sun expects interleukin-23-targeting drugs to stay a preferred treatment option for psoriasis in the US and saw some sales uptick for its Ilumya in that market in Q2, although it isn’t keen on an auto injector option. Management was also upbeat on prospects in China and Japan.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Cardiovascular
- Infectious & Viral Diseases
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Company Type
- Big Pharma
- Parent & Subsidiaries
-
Eli Lilly & Co.
- Alnara Pharmaceuticals Inc.
- Applied Molecular Evolution Inc.
- Armo BioSciences Inc.
- AurKa Pharma Inc.
- Avid Radiopharmaceuticals Inc.
- Chorus
- Chugai Lilly Clinical Research Co. Ltd.
- CoLucid Pharmaceuticals Inc.
- Eli Lilly & Co. (India) Pvt. Ltd.
- Eli Lilly Canada Inc.
- Eli Lilly Deutschland GMBH
- Eli Lilly Japan
- Eli Lilly Ranbaxy Ltd.
- Eli Lilly Suzhou Pharmaceutical Group Co. Ltd.
- Hypnion Inc.
- Icos Corp.
- ImClone Systems Inc.
- InnoCentive LLC
- Lilly Research Centre Ltd.
- Lilly Research Laboratories
- Loxo Oncology Inc.
- Medical Devices & Diagnostics
- Pacific Biotech Inc.
- SGX Pharmaceuticals Inc.
- Senior Management
-
David Ricks, CEO
Joshua L Smiley, SVP, CFO
Daniel M Skovronsky, MD, PhD, SVP, CSO - Contact Info
-
Eli Lilly & Co.
Phone: (317) 276-2000
Lilly Corporate Ctr.
Indianapolis, IN 46285
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice